Is Summit's Ridinilazole a Threat to Acurx's Ibezapolstat in the C.difficile Space?
Source: Dr. KSS, MD, PhD, for Streetwise Reports  (8/10/20)
Dr. KSS, the founder and editor-in-chief of BioPub.co, compares the two drugs as potential treatments for C. difficile. More >

Pharmaceutical Firm Doses First Patient in Phase 2 IPF and Chronic Cough Trial
Source: Streetwise Reports  (8/8/20)
Algernon Pharmaceuticals reported that the first patient has been dosed in the Phase 2 human study of Ifenprodil for treatment of idiopathic pulmonary fibrosis and chronic cough. More >

Biopharma Preparing to Initiate Phase 3 COVID-19 Trial
Source: Streetwise Reports  (8/7/20)
Revive Therapeutics is now "finalizing agreements and aligning resources to initiate the Phase 3 clinical trial in September." More >

Denali Shares Rise 37% on Advancement of DNL151 into Late Stage Parkinson's Trials
Source: Streetwise Reports  (8/6/20)
Shares of Denali Therapeutics reached a new 52-week high after the company reported plans to advance DNL151 in two separate late stage Parkinson's disease clinical studies with its partner Biogen. More >

Biopharma Gets FDA Approval for Phase 3 COVID-19 Trial
Source: Streetwise Reports  (8/4/20)
Revive Therapeutics' trial will test Bucillamine in patients with mild to moderate COVID-19. More >

Ten Good Reasons to Invest Now Pre-Market in Acurx Pharmaceuticals
Source: Dr. KSS, MD, PhD, for Streetwise Reports  (8/3/20)
Dr. KSS, the founder and editor-in-chief of BioPub.co, provides his investment thesis for a company that is promulgating the first new class of antibiotics in 30 years. More >

Kodak Shares Triple in a Flash on $765 Million Loan from DFC for New Pharmaceutical Unit
Source: Streetwise Reports  (7/28/20)
Eastman Kodak shares traded more than 200% higher after the company reported it is forming a new business unit to produce essential pharmaceutical components funded by the U.S. International Development Finance Corporation. More >

TCR2 Therapeutics Reports Positive Results in Mesothelin-Expressing Solid Tumor Study
Source: Streetwise Reports  (7/27/20)
Shares of TCR2 Therapeutics traded 30% higher after the firm released encouraging results from the Phase 1 portion of its clinical study of TC-210 in treating advanced mesothelin-expressing solid tumors.

More >

Milestone Shares More than Double After Presenting Updated Clinical Plan for Heart Condition
Source: Streetwise Reports  (7/23/20)
Shares of Milestone Pharmaceuticals traded 150% higher after the company reported regulatory guidance and updated its clinical development plan for etripamil nasal spray designed for self-administered use in PSVT treatment. More >

Biopharma's Therapeutic Jumps to Phase 2 Testing for COVID-19 'to Shut Down the Cytokine Storm'
Source: Streetwise Reports  (7/22/20)
A development update on Sorrento Therapeutics' three coronavirus-related products is provided in a Dawson James report. More >

Dynavax Shares Rise 20% on Partnership with Mount Sinai to Develop Universal Flu Vaccine
Source: Streetwise Reports  (7/17/20)
Shares of Dynavax Technologies reached a new 52-week high after the company reported that it is collaborating with Mount Sinai to develop a universal influenza vaccine candidate with CpG 1018 adjuvant. More >

AC Immune Shares Rise 19% as Firm Advances Alzheimer's Vaccine in Phase 1b/2a Trial
Source: Streetwise Reports  (7/16/20)
AC Immune SA shares set a new 52-week high after the Swiss biotech firm reported that interim data from its Phase 1b/2a phospho-Tau Alzheimer's Vaccine study reconfirms promising safety and Tau-specific immunogenicity observed in the prior clinical trial. More >

Taiwan Liposome Shares Rise 60% on Inhalable Liposomal HCQ Potential Covid-19 Treatment Claims
Source: Streetwise Reports  (7/15/20)
Shares of Taiwan Liposome Co. reached a new 52-week high after the company released a manuscript describing how its inhalable liposomal hydroxychloroquine may provide clinical benefit and offer a potential treatment for Covid-19. More >

Potential Covid-19 Treatment Is Ready for Prime Time
Source: Streetwise Reports  (7/14/20)
Small-cap Algernon Pharmaceuticals is about to begin a multinational Phase 2b/3 trial for Ifenprodil, a repurposed drug with a known safety record. More >

INmune Bio Shares Double after Reporting Positive Phase 1b Alzheimer's Trial Data
Source: Streetwise Reports  (7/14/20)
Shares of INmune Bio reached a new 52-week high after the company reported interim data from its Phase 1b study of XPro1595 that demonstrated decreased neuroinflammation in Alzheimer's patients. More >

BioNTech Shares Rise as FDA Grants It and Partner Pfizer Fast Track Status for Two Covid-19 Vaccine Candidates
Source: Streetwise Reports  (7/13/20)
Shares of BioNTech SE traded 15% higher after the company reported that, together with its partner Pfizer, it has received FDA Fast Track designation for two separate mRNA-based vaccine candidates against SARS-CoV-2. More >

Threat Detection Company Forms Partnership to Advance Covid-19 Pathogen Screening
Source: Streetwise Reports  (7/12/20)
Patriot One Technologies reported it is collaborating with ecoMine Technologies to advance pathogen screening applications as part of Canada's Digital Technology Supercluster's Covid-19 program. More >

Altimmune Shares Up 20% Upon Forming Partnership for Intranasal COVID-19 Vaccine
Source: Streetwise Reports  (7/9/20)
Altimmune shares reached a new 52-week high after the company reported it is collaborating with DynPort Vaccine on U.S. government funding efforts for AdCOVIDâ„¢, its COVID-19 vaccine candidate. More >

Biotech with Phase 3 Rheumatoid Arthritis and Psoriasis Trials Raises Capital, Now 'Funded Through Catalysts'
Source: Streetwise Reports  (7/8/20)
An update on Can-Fite BioPharma's multiple drug treatment trials is provided in a Dawson James report. More >

Preclinical COVID-19 Vaccine Data 'Encouraging'
Source: Streetwise Reports  (7/8/20)
Updates on Sorrento Therapeutics' two coronavirus-related products are provided in an H.C. Wainwright & Co. report. More >

Biopharma Starts Enrollment Screening for Phase 2 Pulmonary Fibrosis, Cough Trial
Source: Streetwise Reports  (7/8/20)
In the study, Algernon Pharmaceuticals will test an existing drug that is being repurposed for these indications. More >

Analyst: G1 Minimizes the Carnage of Chemotherapy
Source: Streetwise Reports  (7/1/20)
ROTH Capital Partners initiates coverage on U.S. oncology biopharma G1 Therapeutics that is now filing an NDA. More >

'Undervalued' Biopharma Gets Breakthrough Status for Alzheimer's Agitation Drug
Source: Streetwise Reports  (7/1/20)
Axsome Therapeutics' latest news and clinical outlook are discussed in an H.C. Wainwright & Co. report. More >

Life Sciences Firm Submits IND Application to FDA for Phase 3 COVID-19 Study
Source: Streetwise Reports  (7/1/20)
Revive Therapeutics submitted an Investigational New Drug Application to the FDA for a Phase 3 confirmatory study of Bucillamine for treatment in SARS-CoV-2. More >

Akero Therapeutics Shares Rise on Positive Data from Phase 2a NASH Study
Source: Streetwise Reports  (7/1/20)
Akero Therapeutics shares traded 28% higher and established a new 52-week high after the company reported that it recorded positive histological data across all Efruxifermin dosage groups in its Phase 2a BALANCED Study in NASH patients. More >